Wednesday, December 17, 2025
ADVT 
National

CBSA officers seize over 2000 kg of khat, an illegal stimulant in the guise of tea leaves

Darpan News Desk CBSA, 26 Nov, 2021 06:08 PM
  • CBSA officers seize over 2000 kg of khat, an illegal stimulant in the guise of tea leaves

The Canada Border Services Agency (CBSA) is committed to keeping our communities safe from the smuggling of contraband.

On October 4, 2021, CBSA’s Pacific Region Intelligence Section, with assistance from the Agency’s National Targeting Centre, identified a container of interest and referred it for examination. The marine container, imported from Kenya, was declared to contain bags of tea leaves. 

Border services officers from the Metro Vancouver Marine Operations examined the container using a wide range of detection tools and technology, and upon physical inspection, noted discrepancies in the packaging and the substance within the bags. 

“This substantial seizure of khat was the result of a collaborative effort involving officers from the Metro Vancouver Marine Operations, the Pacific Region Intelligence Section, and the National Targeting Centre. It illustrates how thorough inspections of marine containers help to keep illicit and dangerous products out of our communities, which is a responsibility that we take very seriously.”

-Joseph Chayeski, Director, Metro Vancouver Operations Division, Pacific Region, Canada Border Services Agency 

125 bags were found to contain a dried leafy substance which was sent for analysis and identification.

The analysis confirmed the substance as khat (Catha Edulis), a stimulant drug derived from a shrub and indigenous to East Africa and Southern Arabia. Khat and its derivatives are listed under Schedule IV of the Controlled Drugs and Substances Act. The active ingredients contained in khat are cathine and cathinone, which produce a stimulant effect similar to amphetamine when the green parts of the plant are ingested. Khat is a stimulant that since 2005 has been considered by the World Health Organization as an addictive drug of abuse. There are no accepted medical uses for khat.

A total of 2,061 kg of khat was seized. The CBSA has seized 2,296 kg of khat in the first quarter of 2021-2022. 

MORE National ARTICLES

Manage risks, don't close border again: task force

Manage risks, don't close border again: task force
The task force, assembled by the D.C.-based Wilson Center, says a risk-management approach to the border would have been less disruptive and damaging than the "zero-risk" approach that was adopted.

Manage risks, don't close border again: task force

Strong Vancouver Q2 commercial real estate sales

Strong Vancouver Q2 commercial real estate sales
A statement from the board says 726 commercial properties sold in the Lower Mainland between April and June, a nearly 115 per cent increase from sales in the same period last year.

Strong Vancouver Q2 commercial real estate sales

VPD appeals for help to ID knife-wielding man

VPD appeals for help to ID knife-wielding man
The concierge was working at a hotel on Robson Street on October 8 when he confronted a man who had entered the parkade and was peering into cars. The man pulled out a knife and allegedly threatened the hotel employee, before fleeing out to the street.

VPD appeals for help to ID knife-wielding man

Former defence chief to go on trial in May 2023

Former defence chief to go on trial in May 2023
Ten days of trial dates were set during a brief, virtual courtroom hearing this morning, three months after military police charged the former Canadian Armed Forces commander following a sexual misconduct investigation.

Former defence chief to go on trial in May 2023

Federal vaccine rules raise human rights concern

Federal vaccine rules raise human rights concern
The Treasury Board of Canada Secretariat says 240,000 employees have filed their attestations of their vaccine status to the government, out of approximately 268,000.

Federal vaccine rules raise human rights concern

NACI expands booster eligibility guidance

NACI expands booster eligibility guidance
The committee now recommends mRNA boosters to people who received two doses of the Oxford-AstraZeneca vaccine, adults over the age of 70, front-line health-care workers with a short interval between their first two doses, and people from First Nations, Inuit and Métis communities.

NACI expands booster eligibility guidance